PB2130: MAGNETISMM-6: A PHASE 3 STUDY OF ELRANATAMAB + DARATUMUMAB + LENALIDOMIDE VS DARATUMUMAB + LENALIDOMIDE + DEXAMETHASONE IN TRANSPLANT INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
oleh: Sebastian Grosicki, Su-Peng Yeh, Shang-Yi Huang, Ja Min Byun, Christine Dirienzo, Andrea Viqueira
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2023-08-01 |
Deskripsi
No description available for this item.